ANGELHQ CUSTOMER DISCOVERY • NOT A FUNDING ASK

I Am Not Looking for Funding. I Believe Investors May Be the Customer.

When capital is released in stages, investors need to know whether the software evidence supports the technical milestone being claimed.

Investor Technical Assurance applies the Trust Before Ship forensic-audit method to investment stage-gate decisions.

Trust Before Ship gives capital allocators a bounded technical evidence record: what was examined, what findings were located, what obligations failed or remain unverified, and what decision the available evidence supports.

Customer hypothesis under validation
Zero investor engagements today
Technical method demonstrated
Not raising today
ANGELHQ MEETING MATERIALS

Review the customer-discovery materials.

These documents describe the proposed investor use case, the Capital-Gate hypothesis and the questions Trust Before Ship is taking into the AngelHQ conversation.

These materials describe a customer hypothesis under validation. They are not investment recommendations and do not evidence an investor engagement.
THE CUSTOMER HYPOTHESIS

A Defined Capital Decision. A Bounded Technical Record.

Trust Before Ship begins when an investor, fund, accelerator or venture studio must decide whether the supplied software evidence supports the next capital decision.

01

Technical progress can be claimed before it is independently evidenced.

A demo, repository or founder statement may not establish that the claimed milestone is supported by the identified build.

Does the supplied evidence support the capital decision—not merely the presentation?
02

Capital allocators with software risk inside the investment.

The customer hypothesis includes angel investors, venture funds, accelerators, venture studios and other capital providers releasing funds against technical milestones.

Pre-investment Product milestone Follow-on Next tranche
PROPOSED CAPITAL-GATE MODEL

Four possible technical decision positions.

The Capital Gate is a proposed investor-assurance model pending validation. It has not yet been used in an actual investment engagement.

Release

The examined evidence supports the claimed milestone within the stated scope.

Release with conditions

Evidence substantially supports the milestone, with named gaps that should become tranche conditions.

Hold

The evidence contradicts the claimed milestone in a material way.

Insufficient evidence to decide

The evidence available does not permit a conclusion either way.

“Release” is not a clean bill of health or a prediction of startup success. It means only that the examined evidence supports the stated milestone within the declared scope and limitations.
And when the evidence does not support the milestone, the brief says so—including “insufficient evidence to decide.”
THE PROPOSED WORKFLOW

From milestone claim to bounded decision record.

The review does not make the investment decision. It supplies technical evidence that can inform the investor’s own decision process.

01

Claimed milestone

What the company says has been delivered, corrected or made ready.

02

Technical obligations

The important milestone claims translated into checkable terms.

03

Bounded examination

Relevant evidence gathered within the agreed scope, supplied materials and access boundary.

04

Capital Release Technical Brief

What the evidence supports, what contradicts the claim, what remains unresolved and what stays unverified.

CLEAR BOUNDARIES

Bounded technical evidence—not an investment recommendation.

Trust Before Ship does not assess market demand, founder capability, valuation, governance or commercial success.

We report located, reproducible findings. Absence of a finding is not evidence of absence; areas outside the stated scope are marked unverified, never passed.

Outside our purview

  • Market demand
  • Founder or team capability
  • Valuation
  • Governance
  • Legal or regulatory position
  • Sales execution
  • Ultimate commercial outcome

What the evidence may help manage

  • Whether the examined build is identifiable
  • Whether milestone evidence has been supplied
  • Where located findings are concentrated
  • Which obligations failed or remain unverified
  • What technical conditions remain unresolved
  • Whether remediation changed the observed result
INDEPENDENCE MATTERS

We do not profit from the remediation work identified.

Trust Before Ship does not perform or quote for the remediation work it identifies. That preserves independence — we have nothing to gain from the length of the list — and it deliberately gives up repair revenue.

Indicative remediation exposure A bounded range for investigation, repair and retesting effort. Trust Before Ship does not perform or quote for the remediation work identified.
HONEST CURRENT POSITION

Technical evidence exists. Investor demand does not—yet.

We are separating what has already been demonstrated from what still needs to be learned before this can be treated as a real investor-facing product.

DEMONSTRATED
  • Working technical method
  • Five applications examined using aggregated or de-identified evidence
  • Classified findings dataset
  • Repeatable bounded workflow
  • OpenAI Build Week submission completed; result pending
NOT YET VALIDATED
  • Zero investor engagements today
  • Strongest purchase trigger remains unknown
  • Investor evidence threshold remains untested
  • Investor-paid, company-paid and transaction-funded models remain hypotheses
  • Portfolio-wide or repeated use is unproven
NEXT EVIDENCE GATES

Prove investor demand before building the product around it.

Each next step should replace one buyer assumption with observable behaviour.

01

One investor conversation

Confirm whether the problem is recognised and urgent.

02

One live milestone case

Identify one real capital decision where a bounded technical brief could be useful.

03

One pilot engagement

Test scope, evidence expectations, delivery and willingness to pay.

04

One repeated use

Determine whether the same investor, fund or programme would use the model again.

SERVICE FIRST

Start with the decision. Productise only what repeats.

The immediate goal is to validate the investor problem and delivery pattern—not to assume a platform before repeated demand exists.

01

Investor discovery

Validate the buyer, decision point and evidence threshold.

02

Capital Release Technical Brief

Standardise the bounded investor decision record.

03

Repeatable evidence workflow

Productise only the evidence handling and reporting steps that repeat across real engagements.

04

Portfolio assurance layer

Explore recurring stage-gate reviews only after repeated investor demand exists.

COMMERCIAL MODEL UNDER VALIDATION

The first question is not the final price.

The immediate question is whether capital allocators will commission a bounded technical stage-gate review, who pays, and at which investment checkpoint.

Scope and price are set after an initial discussion.

WHAT WE WANT TO LEARN FROM ANGELHQ

This is customer discovery, not fundraising.

We want to understand whether technical stage-gate assurance solves a real problem for capital allocators.

01

Who has the clearest reason to pay first?

The founder, a software agency, or a capital allocator—and why?

02

What is the smallest paid engagement that would count as genuine commercial validation?

What scope, evidence and decision would make a first paid pilot meaningful rather than a discounted favour?

03

What evidence would make an investor comfortable referring a company?

The investor, the company, the fund, the programme or the transaction?

04

Would an investor or fund pay directly for independent technical assurance?

Would this become valuable before investment, at a product milestone, before follow-on capital, or before releasing a tranche?

05

Who should Mohan speak to next?

We are seeking one relevant introduction to a founder, agency, investor, fund, accelerator or portfolio company facing a live technical decision.

WHAT A USEFUL CONVERSATION PRODUCES

A clearer path to the first paying customer—not a funding conversation.

01

Buyer correction

A clearer view of whether the first buyer is a founder, agency or capital allocator.

02

Pilot definition

A clearer view of the smallest paid engagement that would provide meaningful commercial validation.

03

Evidence expectation

The minimum evidence required before a buyer would act, pay or make a referral.

04

Named next conversation

A warm introduction to one relevant buyer or live case.

Praise, encouragement and general interest are not validation outcomes.
INVESTOR MATERIALS

Working customer-discovery materials.

These materials are working customer-discovery documents. They will be revised as buyer evidence, purchase triggers and delivery expectations become clearer.

No document on this page should be treated as an actual investment recommendation or evidence of an investor engagement.
FOUNDER

Engineering discipline applied to capital decisions involving AI-assisted software.

Mohan Iyer is an engineer, former technical project manager and long-standing software and web practitioner. Trust Before Ship applies that engineering discipline to bounded evidence for AI-assisted applications.

Engineering Industrial engineering background with an early specialisation in artificial intelligence.
Software delivery Experience spanning technical project management, web systems and commercial implementation.
Current focus Independent evidence for decisions involving AI-assisted software.
ANGELHQ CUSTOMER-DISCOVERY ASK

Know an investor facing a live technical milestone?

Trust Before Ship is looking for one relevant conversation with an angel, fund, accelerator, venture studio or portfolio company approaching a capital decision tied to technical progress.

No source code or confidential investment material is required for the first conversation.

Bounded technical evidence—not an investment recommendation.

Trust Before Ship reports what the agreed evidence supports within the stated scope. It does not assess market demand, valuation, governance, founder capability or commercial success, and it does not recommend whether an investor should invest.